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PURPOSE. The purpose of this study was to compare optical coherence tomography
angiography (OCTA) and indocyanine green angiography (ICGA) for the assessment of
corneal neovascularization (CoNV).
METHODS. Patients with CoNV extending at least 3 mm into the cornea were included. All
patients underwent corneal imaging at the same visit. Images were recorded using the
AngioVue OCTA system (Optovue, Inc.) with the long corneal adaptor module (CAM-L). ICGA
images were recorded with fluorescent filters using the Heidelberg system (HRA2 Scanning
Laser Ophthalmoscope; Heidelberg Engineering). Images were graded for quality by two
independent observers. Vessel parameters: area, number, diameter, branch and end points,
and tortuosity, were compared between devices. Bland-Altman plots were used to assess
differences between parameters.
RESULTS. Fifteen patients with CoNV predominantly associated with microbial keratitis were
included. Mean subjective image quality score was better for ICGA (3.3 6 0.9) than for OCTA
(2.1 6 1.2, P ¼ 0.002), with almost perfect interobserver agreement for ICGA images (j ¼
0.83) and substantial agreement for OCTA images (j ¼ 0.69). Agreement of grading of all
investigated vessel parameters between ICGA and OCT images was slight to moderate, with
significant differences found for vessel diameter (8.98 lm, P ¼ 0.01, 95% limits of
agreement [LOA]: 15.89 to 2.07), number of branch (25.93, P ¼ 0.09, 95% LOA: 4.31 to
56.17), and terminal points (49, P ¼ 0.05, 95% LOA: 0.78 to 97.22).
CONCLUSION. Compared with ICGA, current OCTA systems are less precise in capturing small
vessels in CoNV complexes, and validation studies are needed for OCTA segmentation
software. OCTA, however, complements ICGA by providing evidence of red blood cell flow,
which together with depth information, may be helpful when planning treatment of CoNV.
Keywords: corneal imaging, cornea neovascularization, optical coherence tomography
angiography, fluorescence angiography, indocyanine green angiography
The human cornea in its healthy state is an avascular tissue,with the dynamic balance between pro- and antiangiogenic
factors actively maintained by the inhibition of immune and
inflammatory events.1 A wide range of inflammatory, infectious,
degenerative, and traumatic disorders may disturb this balance
and lead to corneal neovascularization (CoNV). CoNV is
associated with vision loss and is one of the main causes of
corneal blindness, representing a major public health burden in
developed countries.1,2 In the United States, the prevalence of
CoNV is 4% in the general population, and the incidence per
year is 1.4 million patients.3 CoNV also carries a risk of reduced
graft survival following a corneal transplant.4,5
Fluorescence angiography was recognized as a useful tool
for the evaluation of diseased corneal vessels four decades ago.6
With the advent of new imaging systems and analytical
processes, it has gained growing popularity in the clinical
assessment of CoNV.7–12 The combined use of fluorescein and
indocyanine green angiography (FA and ICGA) has demonstrat-
ed better vessel delineation compared with biomicroscopy
findings, particularly for vessels beneath areas of corneal
scarring.7 In conjunction with objective computer-assisted
image analysis, FA and ICGA provide a reliable method for
assessing CoNV, such as the measurement of multiple vessel
parameters and vessel maturity.13 Comparing CoNV quantita-
tively is a key requirement for guiding and evaluating
treatment.13 Nevertheless, fluorescence angiography remains
an invasive imaging technique, which is not only time-
consuming and examiner dependent, but although rare, also
carries the risk of adverse reactions, such as nausea and
anaphylactic reactions.14
Optical coherence tomography (OCT) is a well-established
noninvasive imaging technique that generates high-resolution
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volumetric (three-dimensional) structural images.15 The axial
resolution of the OCT image data is achieved by measuring the
time of flight of light by utilizing its interference with light sent
down a separate reference path. In early clinical OCT systems,
this was done in time domain (TD) by scanning a mirror in the
reference arm relative to the sample. When the reference path
length matches a signal from the sample an interference
pattern is generated. Modern clinical OCT systems are axially
resolved in the Fourier domain (FD), which improves signal-to-
noise ratio (SNR). In this case, the reference mirror is fixed,
and the light is measured as a function of its frequency. The
Fourier transform of the measured spectrum then gives the
axially resolved signal. The lateral resolution of image data in
current clinical OCT systems works in the same way as laser
scanning confocal microscopy (LSCM), with a single image
spot being laterally scanned across the sample. The three-
dimensional data acquired by OCT can be used to reconstruct
an en face view16 of coronal sections. OCT is also able to
produce functional images of motion by measuring small
changes between consecutive measurements. Quantification of
blood flow by Doppler OCT has been studied since the early
days of OCT.17 There are several methods of doing this
including the Doppler shift of the interference fringes in TD
systems and changes in the pixels Fourier phase between
consecutive measurements in FD systems. The technical
challenges in implementing such precise quantitative systems
in a clinical environment, however, is likely to be the main
factor in why it has not emerged commercially. The problem
can be simplified to a near binary problem of just identifying
where there is significant flow rather than trying to get an
absolute measure of it. This is known as OCT-angiography
(OCTA) and can be implemented by identifying areas where
the OCT signal amplitude varies between consecutive images.
OCTA has recently started emerging for clinical application.17
A major reason for this is the development of more robust
processing methods, such as adding split spectrum decorrela-
tion analysis that splits a FD signal into multiple lower axial
resolution spectral bands before construction of separate OCT
images for each band. The signal de-correlation between
consecutive measurements is calculated for each band and
then averaged. This gives a higher SNR of flow detection,18
which increases the methods robustness. Current clinical
OCTA instruments are designed specifically for the retina due
to the prevalence and clinical importance of blood vessels
within its structure. The use of OCTA for ocular surface vessel
analysis is currently at a clinical experimental stage.19–22
The aim of this study was to evaluate and compare OCTA
with fluorescence angiography for the evaluation of CoNV.
PATIENTS AND METHODS
Patients with clinically evident CoNV on biomicroscopy were
prospectively recruited from the Department of Corneal and
External Eye Disease, Royal Liverpool University Hospital,
United Kingdom, between July and August 2016. Only one eye
of each patient was investigated. In patients with bilateral
CoNV, the eye with more extensive disease on biomicroscopy
was imaged. Inclusion criteria were the presence of CoNV
extending at least 3 mm into the cornea, with or without
corneal scarring, infiltrate or oedema.
Exclusion criteria were less than 18 years of age,
contradictions to undergoing ICGA such as allergies to iodine
or shellfish, renal failure, or pregnancy, or the inability to fixate
on a target due to blindness and/or continuous eye movements
such as nystagmus. All patients underwent imaging (OCTA and
ICGA) during the same visit. Demographics and clinical data
(age, sex, involved eye, diagnosis, best-corrected visual acuity
[BCVA], location and duration of CoNV, and previous
treatment) were included. The location of CoNV was assessed
on slit-lamp biomicroscopy and was defined as superficial if
vessels invaded the cornea in the anterior third of the corneal
stroma and deep if vessels occurred in the mid and posterior
third of the corneal stroma. The study received an Institutional
Review Board approval from the ethical committee of The
Royal Liverpool and Broadgreen University Hospital and was
conducted according to the ethical standards set out in the
1964 Declaration of Helsinki, as revised in 2000. All patients
provided informed consent.
OCTA
Images were recorded using the AngioVue OCTA system
(Optovue, Inc., Fremont, CA, USA) with the long corneal
adaptor module (CAM-L) as previously described.19,20,22 The
device uses a light source centred on 840 nm and a bandwidth
of 45 nm, giving an axial resolution of 5 lm in tissue. The
lateral beam width is 22 lm and lateral sampling is 20 lm. The
A-scan rate is 70,000 per second. The device measures a three-
dimensional scan cube of 6 3 6 3 2.3 mm. The images are
processed using a split-spectrum amplitude de-correlation
angiography (SSADA) algorithm.
After correct positioning of the patient at the device, three
to six corneal scans were performed for each eye using the
manual defocusing method and the AngioRetina scan mode.
Following instructions from the instruments’ manufacturer and
in line with previous studies,19,22–24 the autofocus function
was deactivated. After turning down the background illumina-
tion, the cornea adaptor lens was then moved toward the
corneal surface by advancing the joystick until the corneal
tissue appeared in the OCT window (approximately 2 to 3 cm).
The focal lengths were manually specified by adjusting the
manual F and Z settings (approximately14 andþ14 diopters
[D]) until the vessels in the ROI were clearly in focus. Patients
were instructed to fixate the target during the image
acquisition and avoid blinking or eye movements during the
scanning process.
ICGA
ICGA images were recorded with fluorescent filters before
angiography, as red free, infrared, and fluorescent filters using
the Heidelberg system (HRA2 Scanning Laser Ophthalmo-
scope; Heidelberg Engineering, Heidelberg, Germany) using a
158, 208, or 308 lens with a lens focus between 32 and 53 D.
Following administration of 3 mL ICG, videography was
undertaken for 60 seconds (early phase), commencing 10
seconds after the injection.7,8,13
Image Analysis
The OCTA and ICGA images were independently graded for the
appearance of dye in ICGA images and vessel visibility in OCTA
images by two masked observers (VR and RV) using a
subjective image quality score (0 to 4) as previously published
(0¼no vessel discernible, 1¼poor vessel delineation, 2¼good
vessel delineation, 3 ¼ very good vessel delineation, 4 ¼
excellent vessel delineation).7 For the OCTA images, the signal
strength index (SSI) was recorded (Optovue uses a proprietary
SSI to indicate the signal strength [image quality] of OCT scans
on a scale from 0 to 100 [higher is better]). The best ICGA (late
frames with complete filling of afferent and efferent vessels)
and OCTA images were selected and exported in BMP format
for the purpose of semiautomated quantitative image analysis.
In a first step, the pixel resolution (mm/pixel) of the
selected ICGA images was defined by using the corneal
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diameter (12 mm) as reference distance.7 In a second step, two
landmarks on the ICGA image under consideration were
chosen to define a circular region of interest (ROI) with them
as the end points of its diameter. The same landmarks were
used to define a ROI on the OCTA image while the pixel
resolution of the OCTA image can be derived from the distance
between the two landmarks. This standardization process will
make these two ROIs almost cover the same area of the cornea,
and only vessels within them will be analyzed and compared in
the following step.
In a third step, an in-house automated programme written
in Matlab R2016a 64-bit (The Mathworks, Inc., Natick, MA,
USA) was used to detect and analysed the vessels. This
programme is based on Ref. 7 but has been significantly
improved with a more robust extensively validated segmenta-
tion algorithm.25 More specifically, the eigen-value based filter
was replaced by a local phase based filter for (universal)
optimal enhancement effect on images with large variations
and computation efficiency. To improve the connectivity of the
segmented vessels, an infinite perimeter active contour model
was used to partition the enhanced image into a binary image
(vessel pixels, 1; background, 0). A diagram showing the vessel
parameters is shown in Figure 1 and an example of vessel
segmentation is shown in Figure 2. The segmented vessels
within the ROI were analyzed further to extract parameters
characterizing the vasculature by following.7 For example,
branch point is defined as the location where vessel bifurcates,
whereas end point is where a vessel terminates. A vessel
segment is defined between either two branch points or
between a branch point and an end point. The diameter of a
vessel segment is defined as the average diameter measured
along its path. Parameters, such as vessel area, vessel diameter,
number of branch points, and end points, were compared
between OCTA and ICGA. All the above analyses were
performed on a computer (configurations: Windows7 Service
Pack 1 [Microsoft Corporation, Redmond, WA, USA], Intel
Xeon CPU-E5 [Intel Corporation, Mountain View, CA, USA], 3.0
GHz, and 32 GB of RAM). For demarcation and depth
localization of CoNV on cross-sectional OCTA scans, the
cornea was divided into an anterior, mid-, and posterior
portion. A scale bar was added to the images by dividing the
corneal thickness at the apex into three sections of equal
height.
Statistical Analysis
Quantitative measurements were reported as mean 6 SD and
minimum, median, and maximum. Boxplots were used to
assess normality of data. Wilcoxon rank-signed tests were used
to test for differences. P values of less than 0.05 were
considered statistically significant. Bland-Altman plots were
used to assess agreement between vessel parameter measure-
ments of OCTA and ICGA images and the mean of those
observed differences, with 95% limits of agreement (LOA) and
with 95% confidence interval for LOA are reported.22,26
Cohen’s j statistic was used to test the levels of agreement
between the image quality scores from two observers.
Interpretation of levels of agreement was based on that
recommended for two (binary) categories for each patient.27
At a value of 0.2, j was considered slight, 0.2 < j  0.4 was
considered fair; 0.4 < j  0.6 was considered moderate, 0.6 <
j  0.8 was considered substantial, and j > 0.8 was
considered as almost perfect.
RESULTS
Seventeen patients were recruited. Two patients were exclud-
ed due to poor gaze fixation and resultant poor quality OCTA
images. Fifteen patients (median age, 61 years; range, 29 to 78
years; male-to-female ratio, 8:7) were included with a mean
duration of CoNV of 35 6 41.7 months (median, 18 months;
range, 3 to 141 months). The patient demographics and clinical
features are summarized in Table 1.
Nine eyes had apparent superficial CoNV and six eyes deep
CoNV demonstrated by OCTA (Fig. 3). The mean total vessel
area of CoNV was larger using ICGA compared with OCTA (P¼
0.02) and in only 53% of cases (8 of 15) did the OCTA capture
all of the CoNV area. The mean subjective quality scores for
ICGA and OCTA images were 3.3 6 0.9 and 2.1 6 1.2 (P ¼
0.002), respectively (Fig. 4). Interobserver agreement for the
image quality scores was almost perfect for ICGA images
(weighted Cohen’s j ¼ 0.83) and substantial for OCTA images
(weighted Cohen’s j ¼ 0.69). The mean signal strength index
for OCTA images was 26.4 6 9.8 (min-max, 7 to 42). The signal
strength index was poorer in eyes with corneal scarring (P ¼
0.002) and deep CoNV (P ¼ 0.008), compared with those
without scarring and superficial vessels (Fig. 5A). The image
quality score in eyes with CoNV plus scarring and eyes with
deep CoNV was found to be significantly better using ICGA
compared with OCTA (P ¼ 0.009 and P ¼ 0.03, respectively).
Overview images of the entire cornea could only be acquired
with ICGA due to the limited field of view with OCTA (Fig. 5B).
An overview of the vessel parameter measurements is
summarized in Table 2. Higher values were measured for all
parameters obtained from ICGA images compared with OCTA
images, except for the mean vessel diameter, which was
significantly higher in OCTA images (40.75 vs. 49.73 lm, P ¼
0.01). Significant differences were also found for the number of
terminal points (119.27 vs. 70.27, P ¼ 0.01). The mean
differences and limits of agreement are outlined in Table 3.
Significant mean differences (measurement bias) were found
FIGURE 1. Diagram showing the vessel parameters. In the diagram,
branch points Bi are represented by green circles and end points Ei by
red circles. Vessel segment Si is the vessel between either two branch
points or between a branch point and an end point. In the diagram,
there are five branch points, nine end points, and 12 segments. For
each segment, the diameter of a vessel segment is defined as the
average diameter measured along its path. The number of pixels
belonging to vessels is used to estimate the area of vessels. Please note,
in this diagram, vessel pixels are in black and background is in white
for the best print effect.
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for vessel diameters (8.98 lm, P¼ 0.01, 95% LOA,15.89 to
2.07), number of branch points (25.93, P ¼ 0.05, 95% LOA
4.31 to 56.17), and number of terminal points (49, P¼ 0.05,
95% LOA 0.78 to 97.22), when comparing ICGA and OCTA
images. The variability of the total number of vessels increased
with increasing number of vessels (see Supplementary Data:
Bland-Altman plots).
DISCUSSION
Both the quantitative and qualitative assessment of CoNV are
prerequisites for disease monitoring and planning of treatment.
The biomicroscopic assessment of CoNV, although very useful,
has several limitations for identifying and quantifying CoNV,
especially in the presence of scarring. Previous reports have
demonstrated that fluorescence angiography (ICGA) not only
allows better vessel delineation than biomicroscopy but
provides information on the vessel maturity of CoNV and also
enables the differentiation between afferent and efferent
vessels, which is critical for the planning of treatment such
as selective vessel occlusion with fine needle diathermy.7,8,13
OCTA is an emerging and promising new technique for
noninvasive angiographic imaging. It detects blood vessels by
the temporal variances in amplitude and/or phase of the OCT
signal due to movement of red blood cells.28,29 Current
commercial available OCTA systems have been designed for
retinal vessel analysis and have been successfully used in the
assessment of various vascular pathologies of the posterior
TABLE 1. Patient Demographics and Clinical Data
Patient No.
(Sex, Laterality)
Age
(y) Diagnosis
Duration of
CoNV (mo)
Area of CoNV
(Quadrants)
Location
of CoNV
Corneal
Scarring
Treatment
for CoNV*
BCVA
(logMAR)
1 (F, OS) 35 Rosacea keratitis >6 1 Superficial Yes FND 0.2
2 (F, OD) 79 LSCD >6 4 Superficial and deep No Topical steroids 1
3 (F, OD) 54 HSK >6 1 Superficial Yes Topical steroids 0.8
4 (F, OD) 61 HSK >6 2 Superficial and deep Yes FND 0.8
5 (F, OS) 69 HSK >6 3 Superficial and deep Yes FND 0.6
6 (M, OS) 68 LSCD >6 2 Superficial No Topical steroids 0.2
7 (M, OS) 62 PK (corneal dystrophy) >6 2 Superficial No FND 0.2
8 (M, OS) 71 Rosacea keratitis >6 1 Superficial Yes FND 0.3
9 (F, OS) 39 HSK >6 1 Superficial Yes Topical steroids 0.2
10 (M, OD) 46 Rosacea keratitis >6 2 Superficial and deep Yes FND 0.3
11 (M, OS) 62 HSK >6 1 Superficial and deep Yes Topical steroids 1.0
12 (F, OD) 62 LSCD >6 1 Superficial and deep Yes Topical steroids NPL
13 (M, OD) 31 PK (graft rejection) 3–6 1 Superficial No Topical steroids 0.3
14 (M, OD) 52 PK, HSK 3–6 2 Superficial No Topical steroids 0.2
15 (M, OS) 29 Contact lens-related 3–6 1 Superficial No None 0.1
See Figure 2 for vessel depth location on OCTA. Deep CoNV, vessels located in mid to posterior third the stroma on biomicroscopy; F, female;
FND, fine needle diathermy; HSK, herpes simplex keratitis; LSCD, limbal stem cell deficiency; M, male; NPL, no perception of light; OD, right eye;
OS, left eye; PK, penetrating keratoplasty; superficial CoNV, vessels in the subepithelim and anterior third of stroma, on biomicroscopy.
* All patients received topical steroids before and after FND treatment.
FIGURE 2. (1A) ICGA. (1B) OCTA. (2A) Segmentation of ICGA. (2B)
Segmentation of OCTA.
FIGURE 3. Cross-sectional OCTA scans (left) demonstrating corneal
neovascularization (erythrocyte flow highlighted in red) at different
corneal depths (anterior, mid, or posterior), and corresponding coronal
OCTA scans (right). (A) Superficial vessels located at the level of
epithelium and anterior third of the corneal stroma at the graft-host
interface in a patient with penetrating keratoplasty (Table 1, patient 7).
(B) Deep vessels located in the mid stroma in a patient with recurrent
HSK (Table 1, patient 14). (C) Deep vessels located in the mid and
posterior third of the corneal stroma in a patient with rosacea keratitis
and concomitant corneal scarring (Table 1, patient 1).
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segment.23,24,30,31 In conjunction with a corneal optical
adaptor lens, the same systems can be used for angiographic
anterior segment imaging.19–22 The location of the anterior and
posterior interfaces of the cornea are found by image
segmentation, which can then be used to select manifolds of
set corneal depths. To increase the SNR ratio, a range of
corneal depths can be averaged. This coronal reconstruction
process allows for an instant overview of the corneal pathology
and changes to the length, caliber, and area of CoNV, which is
not possible with B-scan OCT views alone.32 Coronal scans
may also provide information on the depth of invading corneal
vessels.
The current literature on OCTA for the anterior segment
use, however, is sparse.19–22 A previous study by Ang et al.20
compared area of CoNV measurements between OCTA and
ICGA in eight patients and found good agreement with
comparable results for both imaging techniques. In this study,
we analyzed various vessel parameters to further investigate
and better compare OCTA with ICGA for imaging of CoNV. We
found slight to moderate agreement between all investigated
vessel parameters, including the mean overall area of CoNV,
suggesting that the two imaging methods are currently not
interchangeable but may complement each other. OCTA and
ICGA imaging, however, is observer dependent, and possible
measurement bias due to differences in observer experience in
capturing OCTA images with the AngioVue device needs to be
considered. OCTA images were of significantly lower quality
compared with ICGA images (P¼ 0.002; Fig. 4). OCTA was less
accurate in capturing smaller and more distal vessels of the
neovascular networks. Markedly fewer numbers of vessels,
branch points, and end points were detected with OCTA than
with ICGA, which is likely to account for the significant
differences in the mean diameter (P¼ 0.01) and total number
of terminal points (P ¼ 0.01) between the two imaging
methods. In fact, the mean vessel diameter was the only
parameter to show significantly higher values with OCTA
compared with ICGA, which may be explained by the fact that
a smaller mean overall number of vessels captured by OCTA
compared with ICGA and that OCTA performed less well in
capturing smaller size. OCTA is dependent on the movement of
cells, and the images of vessels do not represent the actual
lumen, but movement of erythrocytes; their movement is used
to reconstruct the morphologic appearance of blood ves-
sels.28,33–35 Potential reasons for the poorer performance of the
current OCTA system, compared with ICGA, are that the
motion of erythrocytes may be reduced or absent in vessels
with very small diameters in corneal neovascular networks,
thereby limiting vessel delineation. In addition, the lateral
resolution is limited, and there are artifacts caused by light
scatter, gradient of corneal curvature, and patient eye
movements or blinking during image acquisition. Current
technical issues, which should be rapidly overcome, are
limitations of current image processing algorithms, the need
for instrumentation refinement, such as wider field of view,
improvement of eye tracking and reinclusion of auto focus, and
increased user expertise. A limitation of this and other studies
using OCTA for CoNV is that the software used for deriving
vessel parameters such as segmentation has not been directly
FIGURE 4. (1–3A) ICGA images (208 lens, focus 32 D) of CoNV
secondary to herpes simplex keratitis (Table 1, patient 3, 1A) and
rosacea keratitis (Table 1, patients 8 and 10, 2A and 3A). (1–3B)
Corresponding OCTA images (6 3 6-mm scan size) of the same eyes.
FIGURE 5. (1–3A) Vascularized corneal scar in an eye of a 35-year-old
female patient with rosacea keratitis (Table 1, patient 1). Red free OCT
image (1A), OCTA (6 3 6-mm scan size, 2A), and ICGA (0:17.03, 208
lens, 32 D focus, 2C). (1–3B) A 79-year-old female patient with limbal
stem cell deficiency and 3608 of CoNV (Table 1, patient 2). Color image
(1B), ICGA (1:02.22, 308 lens, 32 D focus, 2B), and OCTA (6 3 6-mm
scan size; 3B). Note the comparably small field width in the OCTA
image.
TABLE 2. Summary of Vessel Parameters
Parameter
ICGA OCTA
P Value*Mean (SD) Min, Max (Med) Mean (SD) Min, Max (Med)
Total vessel area (mm2) 1.92 (1.40) 0.25, 4.17 (1.85) 1.65 (2.68) 0.10, 9.52 (0.61) 0.10
Number of vessels (n) 123.67 (77.24) 20, 267 (119) 83.53 (95.09) 9, 320 (44) 0.08
Branch points (n) 69.40 (42.63) 11.68, 142 (68) 43.47 (52.01) 4, 180 (18) 0.06
Terminal points (n) 119.27 (81.50) 25, 299 (98) 70.27 (67.43) 8, 232 (41) 0.01
Mean vessel diameter (lm) 40.75 (9.70) 23.30, 57.80 (39.80) 49.73 (14.72) 25.40, 77.70 (48.40) 0.01
Mean vessel tortuosity 1.11 (0.05) 1.10, 1.30 (1.10) 1.09 (0.05) 1.00, 1.20 (1.10) 0.20
n¼ 15 eyes.
* Wilcoxon nonparametric signed-rank test.
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validated for anterior segment OCT (AS-OCTA). Although the
software we used has been validated and shown to be robust
and accurate for corneal ICG and fluoroscein angiography,7–13
validation studies for AS-OCTA for CoNV are needed, and
therefore, these results need to be treated with caution.
The OCTA images in our series showed more artifacts in
eyes with CoNV in the presence of scarring or exudates. Also,
the signal strength index of the OCTA images was lower in our
cohort than previously reported in two studies (26.4 6 9.8 vs.
38 6 14 and 36.95 6 13.97, respectively),20,22 possibly due to
differences of clinical presentation of CoNV and the cooper-
ation of patients, which may have also influenced our results. It
is of note that to obtain good images patients need to maintain
fixation for several seconds, which they at times found
difficult.
A main disadvantage of the current AngioVue OCTA system,
however, is the limited field of view, which is restricted to 63
6 mm. In seven eyes, it was not possible to image the full
extent of CoNV with a single scan (Fig. 5B). This is an
important requirement particularly for monitoring disease,
which is achieved with ICGA by the use of different angle
lenses with the Heidelberg Spectralis system, thereby allowing
flexible field of view adjustments during the imaging process.
A similar process would be indicated for OCTA to make OCTA
images comparable.
Although conventional fluorescence angiography (FA and
ICGA) has shown to be a very useful imaging technique to
quantitatively and functionally assess CoNV, lymphatic, and
ghost vessels it has several disadvantages.9–11,36 It is time
consuming and requires intravenous dye injection, it is
contraindicated in pregnant patients or patients with signifi-
cantly impaired liver and kidney function, and it may cause
adverse events such as nausea and less commonly allergic or
anaphylactic reactions. In contrast, the potential advantages of
noncontact and dye-free OCTA are obvious: the technique
allows rapid angiographic image acquisition, is easy to use, and
avoids the need for cannulation and the risk of dye-associated
side effects. Although not capable of differentiating between
active and inactive vessels and to identify afferent efferent
vessels as in the case of conventional fluorescence (FA and
ICG) angiography,10 OCTA enables three-dimensional imaging
with more depth information than conventional fluorescence
angiography, thus potentially providing more objective infor-
mation on the localisation of CoNV. This may be important for
monitoring purposes and of benefit when planning for surgical
procedures such as diathermy or anterior lamellar keratoplas-
ty.22 Although stereo images using ICGA and or FA provides
some depth information, they are not easily quantifiable.7
A key advantage of OCTA may be its suitability for serial
angiographic imaging. A recent case series compared before
and after treatment imaging after a variety of interventions and
reported promising results that support the potential role of
OCTA for monitoring changes in corneal vascular areas.21
Moreover, OCTA may be used to quantify flow rates of
erythrocytes within vessels in neovascular networks as a novel
objective biomarker for assessing CoNV. At present, OCTA is
limited by methodical and technical issues, described above,
causing vessel duplication, residual motion lines and vessel
discontinuity, compared with convention angiography, that
often make the OCTA images difficult to interpret. The most
striking artifacts present in all the OCTA images are line
artifacts. If the patient moves, or blinks, during a B-scan (fast
axis), the OCTA method fails and gives false motion at all
positions on this plane (slow axis). The AngioVue device can
collect the OCT data sets (registration of data sets will be by a
proprietary algorithm) using alternate fast and slow axes
leading to orthogonal line artifacts being present in some
images, particularly Figure 2B. Errors in the segmentation, due
to these false signals, are visible in Figure 5 bottom left.
In conclusion, OCTA is a promising new imaging technique
for CoNV, but our data suggest that the current instrument on
its own is not sufficient for characterizing and monitoring
CoNV. Further technological improvements in OCTA and
optimized image processing algorithms are needed to improve
image quality and reduce projection, shadow, and motion
artifacts, and software validation studies are needed. Combin-
ing OCTA with conventional fluorescence angiography in a
multimodal approach, however, may improve monitoring of
disease and treatment planning but this will require longitu-
dinal studies.
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